Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food Canning Establishment Registration, Process Filing, and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers, 47642-47648 [2014-19241]
Download as PDF
47642
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1119]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Food Canning
Establishment Registration, Process
Filing, and Recordkeeping for Acidified
Foods and Thermally Processed LowAcid Foods in Hermetically Sealed
Containers
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by September
15, 2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0037. Also
include the FDA docket number found
in brackets in the heading of this
document.
SUMMARY:
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Food Canning Establishment
Registration, Process Filing, and
Recordkeeping for Acidified Foods
and Thermally Processed Low-Acid
Foods in Hermetically Sealed
Containers—21 CFR 108.25 and
108.35, and Parts 113 and 114 (OMB
Control Number 0910–0037)—
Revision
tkelley on DSK3SPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Section 402 of the Federal Food, Drug,
and Cosmetic Act (the FD&C Act) (21
U.S.C. 342) deems a food to be
adulterated, in part, if the food bears or
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
contains any poisonous or deleterious
substance which may render it injurious
to health. Section 301(a) of the FD&C
Act (21 U.S.C. 331(a)) prohibits the
introduction or delivery for introduction
into interstate commerce of adulterated
food. Under section 404 of the FD&C
Act (21 U.S.C. 344), our regulations
require registration of food processing
establishments, filing of process or other
data, and maintenance of processing
and production records for acidified
foods and thermally processed low-acid
foods in hermetically sealed containers.
These requirements are intended to
ensure safe manufacturing, processing,
and packing procedures and to permit
us to verify that these procedures are
being followed. Improperly processed
low-acid foods present life-threatening
hazards if contaminated with foodborne
microorganisms, especially Clostridium
botulinum. The spores of C. botulinum
need to be destroyed or inhibited to
avoid production of the deadly toxin
that causes botulism. This is
accomplished with good manufacturing
procedures, which must include the use
of adequate heat processes or other
means of preservation.
To protect the public health, our
regulations require that each firm that
manufactures, processes, or packs
acidified foods or thermally processed
low-acid foods in hermetically sealed
containers for introduction into
interstate commerce register the
establishment with us using Form FDA
2541 (§§ 108.25(c)(1) and 108.35(c)(2)
(21 CFR 108.25(c)(1) and 108.35(c)(2))).
In addition to registering the plant, each
firm is required to provide data on the
processes used to produce these foods,
using Form FDA 2541a for all methods
except aseptic processing, or Form FDA
2541c for aseptic processing of low-acid
foods in hermetically sealed containers
(§§ 108.25(c)(2) and 108.35(c)(2)). Plant
registration and process filing may be
accomplished simultaneously. Process
data must be filed prior to packing any
new product, and operating processes
and procedures must be posted near the
processing equipment or made available
to the operator (21 CFR 113.87(a)).
Regulations in parts 108, 113, and 114
(21 CFR parts 108, 113, and 114) require
firms to maintain records showing
adherence to the substantive
requirements of the regulations. These
records must be made available to FDA
on request. Firms also must document
corrective actions when process controls
and procedures do not fall within
specified limits (§§ 113.89, 114.89, and
114.100(c)); report any instance of
potential health-endangering spoilage,
process deviation, or contamination
with microorganisms where any lot of
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
the food has entered distribution in
commerce (§§ 108.25(d) and 108.35(d)
and (e)); and develop and keep on file
plans for recalling products that may
endanger the public health (§§ 108.25(e)
and 108.35(f)). To permit lots to be
traced after distribution, acidified foods
and thermally processed low-acid foods
in hermetically sealed containers must
be marked with an identifying code
(§§ 113.60(c) (thermally processed
foods) and 114.80(b) (acidified foods)).
The records of processing information
are periodically reviewed during factory
inspections by FDA to verify fulfillment
of the requirements in 21 CFR parts 113
or 114. Scheduled thermal processes are
examined and reviewed to determine
their adequacy to protect public health.
In the event of a public health
emergency, records are used to pinpoint
potentially hazardous foods rapidly and
thus limit recall activity to affected lots.
As described in our regulations,
processors may obtain the paper
versions of Forms FDA 2541, FDA
2541a, and FDA 2541c by contacting us
at a particular address. Processors mail
completed paper forms to us. However,
processors who are subject to §§ 108.25,
108.35, or both, have an option to
submit Forms FDA 2541, FDA 2541a,
and FDA 2541c electronically (see 76 FR
11783 at 11785, March 3, 2011).
In a notice published in the Federal
Register of September 18, 2013 (78 FR
57391) (the September 18, 2013 notice),
we provided notice that we are updating
the process filing portion of the
electronic submission system to
incorporate ‘‘smartform’’ technology.
The updated process filing portion of
the electronic submission system will
query the processor about the processes
used to produce the food and present
only those data entry fields that are
applicable. This will reduce the burden
on processors and reduce errors in
process filing because processors will
no longer need to evaluate whether
particular data entry fields are
applicable to their products. For
example, when a processor submits a
process filing for a product that is
processed using a low-acid retorted
method with a process mode of
‘‘agitating,’’ smartform technology
would bypass questions that are not
applicable to this process mode option.
Although we encourage commercial
processors to use the electronic
submission system for plant registration
and process filing, we will continue to
make paper-based forms available. To
standardize the burden associated with
process filing, regardless of whether the
process filing is submitted electronically
or using a paper form, we are proposing
to eliminate Forms FDA 2541a and FDA
E:\FR\FM\14AUN1.SGM
14AUN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
2541c and replace these two forms with
a total of four forms. Each of the four
proposed replacement forms will
pertain to a specific type of commercial
processing and will be available both on
the electronic submission system and as
a paper-based form. The electronic
submission system and the paper-based
form will ‘‘mirror’’ each other to the
extent practicable. The four proposed
replacement process filing forms are as
follows:
• Form FDA 2541d (Food Process
Filing for Low-Acid Retorted Method);
• Form FDA 2541e (Food Process
Filing For Acidified Method);
• Form FDA 2541f (Food Process
Filing for Water Activity/Formulation
Control Method); and
• Form FDA 2541g (Food Process
Filing for Low-Acid Aseptic Systems).
Some of the data entry fields on the
four proposed replacement process
filing forms are not on current Forms
FDA 2541a and FDA 2541c. We added
certain data entry fields to improve the
efficiency of our review of the process
filings. For example, the four proposed
replacement forms include data entry
fields for the ‘‘food product group’’
(such as liquid, ready-to-eat ‘‘breakfast
foods’’). We estimate that any time it
would take to provide such information
not already on Form FDA 2541a or FDA
2541c would be offset by the time
processors will save by not having to
evaluate whether certain data entry
fields on Form FDA 2541a or FDA
2541c are applicable to their products.
In accordance with 5 CFR 1320.8(d),
we requested public comment on the
proposed information collection in the
September 18, 2013, notice. We
extended the comment period for an
additional 90 days on November 18,
2013. We received five comments in
response to the notice, each addressing
one or more topics.
(Comment 1) One comment
expressed concern that it would have to
resubmit all previously submitted
process filings.
(Response) There is no need to
resubmit previously submitted process
filings. Previously submitted process
filings will remain valid provided that
the information in the previously
submitted filings is still current.
(Comment 2) One comment
expressed concern that we are planning
to eliminate electronic submission.
(Response) We are not planning to
eliminate electronic submission for
process filing and registration. When we
published the notice on September 18,
2013, we made the revised paper forms
available for review so that interested
parties could comment on their content
and format. As a result of the comments,
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
we have updated the draft revised
forms. Once we receive OMB approval
of the revised information collection, we
will update the electronic system so that
the information requested in the
electronic system mirrors the
information requested on the revised
paper forms.
(Comment 3) One comment asserted
that we do not have legal authority to
use Form FDA 2541e for the purpose of
submitting a voluntary process filing.
(Response) We disagree with the
comment’s assertion that we do not
have the legal authority to permit a
manufacturer to provide a voluntary
process filing submission to FDA on
Form FDA 2541e. The scope of the
voluntary submission discussed in this
document is limited to certain food
products (that is, fermented foods that
have a finished equilibrium pH of 4.6 or
below and acid foods with small
amounts of added low-acid ingredients)
whose regulatory classification is not
obvious when we look at the product
and the product label. FDA has long
regarded it to be a prudent practice for
manufacturers of foods to work
cooperatively with FDA to ensure that
their products are safe and comply with
all applicable legal requirements.
Consequently, we have proposed to
institute the voluntary consultation
process discussed in this document. The
draft guidance document, ‘‘Guidance for
Industry: Submitting Form FDA 2541
(Food Canning Establishment
Registration) and Forms FDA 2541d,
FDA 2541e, FDA 2541f, and FDA 2541g
(Food Process Filing Forms) to FDA in
Electronic or Paper Format (January
2014),’’ available on FDA’s Web site at
https://www.fda.gov/FoodGuidances,
describes the scope and purpose of this
process in section II.C, and we expect to
issue final guidance on or about the date
that Form FDA 2541e becomes
operational, along with the other revised
forms discussed in this document. The
ability to submit a voluntary submission
fosters communication by encouraging
manufacturers to submit their
processing techniques to FDA for an
early evaluation of whether their
product satisfies the criteria for being
excluded from the coverage of part 114.
Such communication will help to
ensure that any potential food safety
issues are resolved before the product is
marketed and will help to ensure that
processing techniques used by
manufacturers are in full compliance
with the standards of the FD&C Act.
FDA is instituting this voluntary
consultation process under our broad
statutory authority, found in section
1003 of the FD&C Act (21 U.S.C. 393),
to protect the public health by ensuring
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
47643
that foods are safe, wholesome, sanitary,
and properly labeled and the
prohibitions regarding adulterated food
in section 402(a)(1) of the FD&C Act (21
U.S.C. 342(a)(1)).
(Comment 4) One comment
expressed concern that a manufacturer
of a product that satisfies the criteria for
being excluded from the coverage of
part 114 who submits a voluntary
submission will be held to the same
regulations that acidified products are
held to with regard to inspections and
recordkeeping. As a result, we would be
making substantial changes to part 114
without notice and comment
rulemaking.
(Response) A voluntary process
filing submission to FDA on Form FDA
2541e allows manufacturers to submit
their processing techniques to FDA for
an early evaluation of whether their
product satisfies the criteria for being
excluded from the coverage of part 114.
If the product satisfies the criteria for
being excluded from the coverage of
part 114, the product is not subject to
the inspection and recordkeeping
regulations in part 114 and has not
become subject to those regulations as a
result of the submission and
consultation. However, if after careful
review of the voluntary submission we
conclude that the product does not
satisfy the criteria for being excluded
from the coverage of part 114, then we
would advise the manufacturer of our
determination that the product is an
acidified food subject to part 114 and
that a process filing as an acidified food
must be submitted for the product.
(Comment 5) One comment
expressed concern that the ‘‘voluntary
process filing’’ is not ‘‘voluntary’’
because it asserted our inspectors will
expect all manufacturers of products
that are excluded from the coverage of
part 114 to voluntarily file, thereby
making the process effectively
mandatory.
(Response) The voluntary
submission process is only available to
manufacturers of certain food products
(that is, fermented foods that have a
finished equilibrium pH of 4.6 or below
and acid foods with small amounts of
added low-acid ingredients) whose
regulatory classification is not obvious
when we look at the product and the
product label. For example, we can
easily determine that products such as
refrigerated foods and carbonated
beverages are excluded from the
coverage of part 114 by looking at the
product or the product label. In
response to comments, we have revised
our guidance and the instructions for
voluntary submissions to clarify those
products for which a voluntary
E:\FR\FM\14AUN1.SGM
14AUN1
tkelley on DSK3SPTVN1PROD with NOTICES
47644
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
submission would or would not be
accepted. In the event that we receive a
voluntary submission for a product that
is not eligible for the review, we will
respond to the submission by notifying
the manufacturer of the error. We will
not add the product to our database.
Thus, ineligible submissions will be
rejected and will not result in additional
information in our database. In
summary, our inspectors will not expect
all manufacturers to submit voluntary
submissions because not all products
are eligible for the process and no
advantage is obtained from a voluntary
submission for an ineligible product.
(Comment 6) One comment
expressed concern that voluntary
submitters who choose to use the
electronic submission system would not
be able to access and view their
submissions.
(Response) A voluntary submission
on Form FDA 2541e that is submitted
electronically may be accessed and
viewed in the same manner as a
required process filing on Form FDA
2541e that is submitted electronically.
(Comment 7) One comment
suggested that voluntary submission
may create confusion by subjecting a
non-covered product (that is a
refrigerated food or a fermented food) to
the acidified food regulations,
(Response) As discussed in the
response to Comment 4, if a product
satisfies the criteria for being excluded
from the coverage of part 114, the
product is not subject to the inspection
and recordkeeping regulations in part
114 and will not become subject to
those regulations as a result of a
voluntary submission. We can easily
determine that some products such as
refrigerated foods and carbonated
beverages are excluded from the
coverage of part 114 by looking at the
product or the product label. The
voluntary submission process is only
available to manufacturers of certain
food products (that is, fermented foods
that have a finished equilibrium pH of
4.6 or below and acid foods with small
amounts of added low-acid ingredients)
whose regulatory classification is not
obvious when we look at the product
and the product label.
(Comment 8) One comment stated
that the current, ‘‘Acidified and LowAcid Canned Foods: Draft Guidance:
Acidified Foods (September, 2010),’’
does not provide guidance on what
constitutes a fermented food.
(Response) As discussed in section
III.C of the guidance, fermented foods
(such as some kinds of sauerkraut,
cucumber pickles, and green olives) are
low acid foods that have been subjected
to the action of microorganisms to
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
reduce the pH of the food to 4.6 or
below.
(Comment 9) One comment
suggested that the voluntary submission
process creates unnecessary burdens for
both industry and FDA and that there
will be no benefit derived from the
consultation process.
(Response) Manufacturers are free to
decide whether to make a voluntary
submission, and we believe that some
manufacturers may choose to do so to
participate in the voluntary consultation
process. Such consultation may enable
us to more easily determine the
regulatory classification of a product.
For a domestic product, this may reduce
the time it takes for us to complete a
facility inspection. With regard to a food
product that will be offered for import
into the United States, this may enable
us to reduce the time it takes to
authorize release of the product at the
border. For FDA, the voluntary
submission results in increased
efficiency.
(Comment 10) Because FDA Form
2541e does not have to be filled out in
its entirety, the comment argued that
voluntary filing does not result in
benefits to food safety. The comment
suggested that a better voluntary
program would be one in which a
processor could submit a scheduled
process for a food to seek our
assessment of the systems in place to
assure the safety of the food, not just as
a way to determine if a product is
acidified or not.
(Response) As discussed in the
response to Comment 4, a voluntary
process filing submission to FDA on
Form FDA 2541e allows manufacturers
to submit their processing techniques to
FDA for an early evaluation of whether
their product satisfies the criteria for
being excluded from the coverage of
part 114. If we conclude that the
product does not satisfy the criteria for
being excluded from the coverage of
part 114, then we would advise the
manufacturer of our determination that
the product is an acidified food subject
to part 114 and that a process filing as
an acidified food must be submitted for
the product. This results in proper
regulatory classification of the product
and appropriate FDA review of the
processing technique, thereby
enhancing food safety.
We appreciate the comment’s
suggestions for expanding the voluntary
submission program, but we note that
the expansion suggested by the
comment is not within the scope of the
revisions to Form FDA 2541e. The
paperwork reduction analysis only
estimates the additional paperwork
burden associated with voluntary
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
submission on Form FDA 2541e of
information for food products, limited
to those the regulatory classification of
which is not obvious when we look at
the product and the product label.
(Comment 11) One comment
suggested that Form FDA 2541e does
not provide the flexibility needed for
manufacturers to report their processes.
The comment indicated that the draft
form only provides ‘‘one size fits all’’
mandatory processing parameters by
listing limited options for processors to
choose from.
(Response) When we revised Form
FDA 2541e, we listed all the current
processing methods used by industry,
and included an ‘‘Other’’ choice for
many fields to permit manufacturers to
report new and emerging methods that
may be developed in the future. As a
result of these revisions, the form
provides the flexibility needed to
describe any process. In addition, we
issued a draft guidance describing the
revised forms and provided interested
parties an opportunity to comment on
alternative processes that we should
include on the forms.
(Comment 12) One comment
suggested that a processor should be
able to submit one Form FDA 2541e that
describes a process for multiple forms of
a product (e.g., ‘‘fresh pack pickles
(whole, cut or sliced)’’), multiple
product packing mediums, and multiple
product names that indicate minor
formulation changes, provided that the
preparation of these products follows
the identical scheduled process.
(Response) We agree that, under the
appropriate circumstances, a processor
should be able to submit one paper
Form FDA 2541e that describes a
process for multiple forms of a product.
In the past, a processor could complete
Form FDA 2541e in the manner
described. The revised paper version of
Form FDA 2541e may still be prepared
in this manner, provided that the
multiple forms of the product all follow
the identical scheduled process and
other factors (e.g., container type or size)
do not make it necessary to submit a
separate filing. The paper version of
revised Form FDA 2541e will allow a
processor to enter (1) multiple product
forms (e.g., ‘‘fresh pack pickles (whole,
cut or sliced)’’), (2) multiple product
packing mediums (such as brine, oil,
sauce), and (3) multiple product names
that indicate minor formulation changes
(such as hot, medium, mild salsa).
(Comment 13) One comment stated
that we do not need percent headspace
information on a process filing for an
acidified product and, if the form
includes the data element, then we
should provide enough room on the
E:\FR\FM\14AUN1.SGM
14AUN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
form for a processor to identify multiple
percent headspace figures associated
with multiple container sizes.
(Response) Information regarding
the percent headspace information on a
process filing for an acidified product
may help us analyze a processing
method that uses overpressure. While
overpressure typically is used for low
acid products that are thermally
processed at elevated temperatures,
overpressure may also be used for an
acidified product. Thus, revised Form
FDA 2541e includes a data field for
percent headspace. If overpressure is
not being used, the correct response is
‘‘N/A.’’
We also disagree that we should allow
a processor to identify multiple figures
associated with multiple container sizes
on a single process filing. A process
filing may not be submitted for multiple
container types or sizes to prevent the
detention of product where multiple
types or sizes are on one submission
and only part of the submission (e.g.,
one container size and/or type) is
questionable from a food safety
perspective. A separate Form FDA
2541e is needed for each container type
or size. Because a separate Form FDA
2541e is needed for each container type
or size, room for multiple entries for
headspace associated with multiple
container sizes is not necessary.
(Comment 14) One comment
suggested that we clarify how to
complete the data field, ‘‘What is the
vacuum,’’ in section C.2 of revised Form
FDA 2541e when the processor has a
range of values to report.
(Response) We revised the
instructions for section C.2 of Form FDA
2541e to clarify that the processor of an
acidified food that is vacuum packed
should report the minimum value if
there is a range of values for the
vacuum.
(Comment 15) One comment
suggested that we add ‘‘Center
Temperature’’ as a thermal process
mode in section G of revised Form FDA
2541e. The comment described ‘‘Center
Temperature’’ as a process in which the
processor punctures the lid and inserts
a thermometer into the container to take
a center temperature reading. When the
center temperature reaches the
appropriate temperature, the processor
begins the time count. The comment
explained that the center temperature
method differs from the other methods
because the time count does not begin
when the container is filled or the lid is
placed on the container but instead
begins when the center temperature
reaches the specified temperature. In
addition, the comment requests that
center temperature be added as a choice
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
in the ‘‘Note’’ under Section D
(Container Size) that references specific
thermal processing mode for which the
processor may choose to report volume
rather than container dimensions.
(Response) We disagree with the
comment’s suggestion to add ‘‘Center
Temperature’’ as a thermal process
mode in section G and as a choice in the
‘‘Note’’ under section D of revised Form
FDA 2541e. ‘‘Center temperature’’ is not
a thermal process mode because it does
not include a defined scheduled
process. A scheduled process for
acidified foods can consist of a
minimum of two components as in the
case of a ‘‘hot fill and hold’’ or as many
as three components for products that
are processed using one of the other
processing modes selected. The term
‘‘center temperature’’ or ‘‘center can
temperature’’ refers to the temperature
of the product achieved at the end of the
completed scheduled process and not a
thermal process mode in and of itself.
(Comment 16) One comment
suggested that we clarify where to report
the maximum pH value on Form FDA
2541e.
(Response) We no longer request the
maximum pH value of the product on
draft Form FDA 2541e. We revised the
form to refer to the ‘‘finished
equilibrium pH’’ value of the product
for consistency with the use of that term
in § 114.80. We revised the instructions
for section E.2 of Form FDA 2541e to
clarify that the finished equilibrium pH
should be reported.
(Comment 17) One comment
suggested that we add ‘‘critical to the
scheduled process’’ to the term
‘‘Microbial Preservative(s)’’ in section
E.6 of draft Form FDA 2541e. The
comment explained that some
preservatives are added for purposes
other than controlling the growth of
microorganisms and should not be part
of the scheduled process.
(Response) We revised the title of
section E.6 of draft Form FDA 2541e to
read ‘‘Microbial Preservative(s) Critical
to the Scheduled Process.’’
(Comment 18) One comment
suggested we clarify that trade
associations are an appropriate source
for a scheduled process.
(Response) Trade associations may
provide the scientific support for a
scheduled process. In response to the
comment, we have revised our
instructions to include a reference to
‘‘organization’’ which by definition
would include trade associations in the
list of examples for the term ‘‘process
source.’’
(Comment 19) One comment asked
us to clarify how to fill out section I on
Form FDA 2541e for companies that use
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
47645
center temperature, particularly with
respect to columns 1, 2, 3, 5, and 7.
(Response) As discussed in the
response to Comment 15, we disagree
that ‘‘center temperature’’ is a thermal
process mode. The term ‘‘center
temperature’’ or ‘‘center can
temperature’’ refers to the temperature
of the product achieved at the end of the
completed scheduled process and not a
thermal process mode in and of itself.
The center temperature is the end point
achieved by the scheduled process and
is not the scheduled process itself. The
instructions for Form FDA 2541e
provide step-by-step directions for how
to fill out each section of the form.
(Comment 20) One comment noted
that the draft guidance document,
‘‘Acidified and Low-Acid Canned
Foods: Draft Guidance: Acidified Foods
(September, 2010),’’ has not been
finalized and suggested that we should
refrain from revising the process filing
forms until the guidance has become
final. The comment expressed concern
that the ‘‘Food Product Group’’
categories might be affected by possible
changes to the draft guidance.
(Response) The draft acidified foods
guidance is intended to help
commercial food processors in
determining whether their food
products are subject to the regulations
for acidified foods and provides our
thinking on several topics related to the
processing of, and process filings for,
acidified foods. We have prepared a
separate draft guidance document that
focuses on procedures for submitting
the revised process filing forms. The
draft guidance entitled ‘‘Guidance for
Industry: Submitting Form FDA 2541
(Food Canning Establishment
Registration) and Forms FDA 2541d,
FDA 2541e, FDA 2541f, and FDA 2541g
(Food Process Filing Forms) to FDA in
Electronic or Paper Format (January
2014),’’ is available on FDA’s Web site
at https://www.fda.gov/FoodGuidances.
As discussed in the response to
Comment 3, we expect to issue this
guidance as final guidance on or about
the date that the revised forms become
operational. Further, we disagree that
the ‘‘Food Product Group’’ categories
might be affected by possible changes to
the draft acidified foods guidance. The
‘‘Food Product Group’’ categories
correspond to the first two digits of the
FDA Product Code and would not be
affected by changes to the draft acidified
foods guidance.
(Comment 21) One comment
suggested that we remove the ‘‘Food
Product Groups’’ category of ‘‘Dressings/
condiments (e.g. salad dressing,
chutney, salsa, pepper sauce, etc.)’’ from
all process filing forms because all
E:\FR\FM\14AUN1.SGM
14AUN1
tkelley on DSK3SPTVN1PROD with NOTICES
47646
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
dressings and sauces with a pH of 4.6
or below should be considered acid
foods.
(Response) The definition of
acidified foods in § 114.3(b) only
excludes from the coverage of part 114
those dressing and condiments that are
acid foods that contain small amounts of
low-acid ingredients and have a
resultant finished equilibrium pH that
does not significantly differ from that of
the predominant acid or acid food. We
included the ‘‘Food Product Group’’
category, ‘‘Dressings/condiments (e.g.
salad dressing, chutney, salsa, pepper
sauce, etc.),’’ on the forms to
accommodate the possibility that some
dressings and condiments may not
satisfy these criteria.
(Comment 22) One comment
expressed concern that the ‘‘Food
Product Group’’ categories for various
fruit and vegetable juices indicates that
FDA considers all fruit and vegetable
juices to be subject to the acidified foods
regulations and, therefore, will require
process filings for all fruit and vegetable
juices.
(Response) The definition of
acidified foods in § 114.3(b) excludes
from the coverage of part 114 those fruit
and vegetable juices that meet the
definition of 21 CFR 120.1(a) and have
a finished natural pH of 4.6 or below.
We included ‘‘Food Product Group’’
categories for various fruit and vegetable
juices on all the forms (forms for lowacid foods as well as forms for acidified
foods) to accommodate the possibility
that some fruit and vegetable juices may
not satisfy these criteria.
(Comment 23) One comment
suggested we should eliminate the
optional ‘‘Food Product Group’’
categories from the process filing forms
to make the forms easier to complete.
(Response) Because the ‘‘Food
Product Group’’ information is optional,
a manufacturer or packer that chooses
not to provide the information may
simply skip that section of the form.
(Comment 24) One comment
questioned the value of the optional
‘‘Food Product Group’’ category
information. Another comment asserted
that parts of the revised forms appear to
be directed toward generating what it
characterized as facility profiles, which
it further characterized as extraneous
information not relevant to public safety
and, thus, unnecessary.
(Response) As discussed in section I
of this notice, improperly processed
low-acid foods present life-threatening
hazards if contaminated with foodborne
microorganisms, especially C.
botulinum. The spores of C. botulinum
need to be destroyed or inhibited to
avoid production of the deadly toxin
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
that causes botulism. This is
accomplished with good manufacturing
procedures, which must include the use
of adequate heat processes or other
means of preservation. To protect the
public health, our regulations in parts
108, 113, and 114 require registration of
food processing establishments, filing of
process or other data, and maintenance
of processing and production records for
acidified foods and thermally processed
low-acid foods in hermetically sealed
containers. We review the process
filings to determine their adequacy to
protect public health. In the event of a
public health emergency, records are
used to pinpoint potentially hazardous
foods rapidly and thus limit recall
activity to affected lots.
We interpret the comment regarding
‘‘facility profiles’’ as objecting to our
intent to permit manufacturers to
voluntarily self-categorize the product
for which they are submitting a process
filing as one of several optional ‘‘Food
Product Group’’ categories. When this
optional information about the ‘‘Food
Product Group’’ category is provided,
we will use it to help us understand the
nature of the products covered by the
process filing as we review the
scheduled process described in the
filing for adequacy to control microbial
contamination to ensure safe
manufacturing, processing, and packing
procedures. We will also use the ‘‘Food
Product Group’’ category information, in
addition to our general knowledge of the
industry and the reports we receive,
such as those under §§ 108.25(d) and
108.35(d) regarding instances of
potential health-endangering spoilage,
process deviation, or contamination
with microorganisms, to prioritize
which facilities to inspect.
(Comment 25) One comment
suggested that, to eliminate confusion,
we should use ‘‘import codes’’ from the
U.S. International Trade Commission to
clarify the ‘‘Food Product Group’’
categories.
(Response) We disagree that using a
coding system such as the ‘‘Harmonized
Tariff Schedule of the United States
Annotated’’, which provides the
applicable tariff rates and statistical
categories for all merchandise imported
into the United States, would eliminate
confusion. The ‘‘Food Product Group’’
categories identifies to FDA a ‘‘group’’
of foods that will help us determine the
product submission (such as Baby Food
or Soup) and prioritize facilities to
inspect from a food safety perspective.
The ‘‘Food Product Group’’ categories
correspond to the first two digits of the
FDA Product Code, also referred to as
the Product Industry Code. We have
been using this coding system for
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
decades, and so we believe that using
‘‘import codes’’ rather than our
longstanding coding system would not
enhance our ability to track and identify
potentially adulterated products as well
as groups of foods for potential health
hazards.
(Comment 26) One comment
asserted that we have increased the
information being requested by 30
percent and, since this increase should
be reflected in the time needed to
complete the forms, we underestimated
the reporting burden in table 1.
(Response) We disagree that we have
increased the information being
requested or underestimated the time it
takes to complete the paper forms. We
updated the paper forms to provide
responsive information in the form of
check boxes. This responsive
information has been reported by
industry for decades without being
provided as check boxes on the paper
forms. Adding these check boxes makes
the forms longer, but does not increase
the information being requested.
Instead, the new forms should reduce
the time it takes to complete the process
filing because a submitter may check a
box rather than prepare and manually
enter on the paper form a written
description of a process. We note that
substantial time may be saved by
submitters that use the electronic
submission system. The electronic
submission system will present only
those sections of the form that are
relevant to the subject matter of the
submission, as determined by the
information submitted in response to
the initial questions. The system will
also minimize the submission of
incomplete forms, thus saving time that
paper form submitters will spend if it
becomes necessary to correct a form and
submit it again. Finally, we note that, to
the extent that the comment is referring
to the optional ‘‘Food Product Group’’
categories, we estimate that the
information is readily available to a
submitter and easily provided by
checking a box. In summary, we have
not increased or decreased our estimate
of the total time necessary to complete
the new process filing forms because: (1)
We have not increased the required
information in a process filing; (2) the
new forms should reduce the time it
takes to complete the process filing
because a submitter may check a box
rather than prepare and manually enter
on the form a written description of a
process; and (3) the ‘‘Food Product
Group’’ category information is
optional, readily available, and
provided by checking a box.
(Comment 27) One comment
asserted that we underestimated the
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
number of hours it takes to comply with
recordkeeping requirements in parts
108, 113, and 114, as reported in table
2. The comment stated that a canning
establishment running a single line
operation with one 8-hour shift 5 days
a week for 52 weeks each year would
conduct manufacturing operations for
2,080 hours each year, and the
recordkeeping would occupy 25 percent
of the time of one full-time employee, or
520 hours per year, which is greater
than our estimate of 250 hours. The
comment added that, for a facility
operating multiple processing lines and/
or multiple shifts per day, the
recordkeeping burden would be greater.
(Response) We appreciate the
information provided by the comment.
Since the information relates the
recordkeeping experience of a single
line operation, without additional
information we do not have a sufficient
basis for revising the estimated average
number of hours of recordkeeping
undertaken by all respondents, across
various sizes and types of processing
facilities. Accordingly, for the purpose
of this information collection request,
we are retaining our previous estimate.
However, in preparation for the next
regular information collection request,
we will consult with several
establishments of varying sizes and
types to obtain additional data on the
recordkeeping burdens and reevaluate
our estimates. We will then publish the
revised estimates for comment and
consider additional information
submitted in response.
(Comment 28) One comment asked
us to consult select companies before
finalizing the revised forms, in order to
obtain these companies’
recommendations regarding the content
of the forms, as part of a transparent,
collaborative effort.
(Response) Section 3506(c)(2)(A) of
the PRA (44 U.S.C. 3506(c)(2)(A))
requires us to provide notice and a 60day comment period before submitting
the information collection to OMB.
Section 3507(a)(1)(D) of the PRA (44
U.S.C. 3507(a)(1)(D)) requires us to
publish a second notice announcing our
submission of the Information
47647
Collection Request to OMB and
providing a 30-day comment period
during which interested parties may
submit their comments directly to OMB.
These processes are open to all
interested parties rather than to ‘‘select
companies.’’ Thus, interested parties
had sufficient opportunity to comment.
As discussed in our responses to the
comments, we have modified the paperbased versions of the four proposed
replacement forms and their
instructions. We have also modified the
electronic submission system to mirror
the paper forms. At this time, these
documents are available for review on
OMB’s Web site as part of the
Information Collection Request we
submitted to OMB.
Description of Respondents: The
respondents to this information
collection are commercial processors
and packers of acidified foods and
thermally processed low-acid foods in
hermetically sealed containers.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
FDA form
number
21 CFR section
108.25(c)(1) and 108.35(c)(2); Food canning establishment registration.
108.25(c)(2); Food process filing for acidified method.
108.35(c)(2); Food process filing for lowacid retorted method.
108.35(c)(2); Food process filing for water
activity/formulation control method.
108.35(c)(2); Food process filing for lowacid aseptic systems.
108.25(d); 108.35(d) and (e); Report of any
instance of potential health-endangering
spoilage, process deviation, or contamination with microorganisms where any lot
of the food has entered distribution in
commerce.
Total .......................................................
1 There
Total annual
responses
Average burden
per response
Total
hours
2541
645
1
645
0.17 (10 mins.) ...
110
2541e
726
11
7,986
0.33 (20 mins.) ...
2,659
2541d
336
12
4,032
0.33 (20 mins.) ...
1,343
2541f
37
6
222
0.33 (20 mins.) ...
74
2541g
42
22
924
0.75 (45 mins.) ...
693
N/A
1
1
1
4 ..........................
4
........................
........................
........................
........................
.............................
4,883
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of the number
of respondents in table 1 on
registrations, process filings, and reports
received over the past 3 years. The
hours per response reporting estimates
are based on our experience with
similar programs and information
tkelley on DSK3SPTVN1PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
received from industry. The reporting
burden for §§ 108.25(d) and 108.35(d)
and (e) is minimal because notification
of spoilage, process deviation, or
contamination of product in distribution
occurs less than once a year. Most firms
discover these problems before the
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
product is distributed and, therefore, are
not required to report the occurrence.
We estimate that we will receive one
report annually under §§ 108.25(d) and
108.35(d) and (e). The report is expected
to take 4 hours per response, for a total
of 4 hours.
E:\FR\FM\14AUN1.SGM
14AUN1
47648
Federal Register / Vol. 79, No. 157 / Thursday, August 14, 2014 / Notices
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
21 CFR section
Number of
recordkeepers
Number of
records per
recordkeeper
Total annual
records
Average
burden per
recordkeeping
Total hours
113.100 and 114.100 ...........................................................
10,392
1
10,392
250
2,598,000
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of 10,392
recordkeepers in table 2 on its records
of the number of registered firms,
excluding firms that were inactive or
out of business, yet still registered. To
avoid double-counting, we have not
included estimates for § 108.25(e), (g),
and (h) because they merely crossreference recordkeeping requirements
contained in parts 113 and 114 and have
been accounted for in the recordkeeping
burden estimate. We estimate that
10,392 firms will expend approximately
250 hours per year to fully satisfy the
recordkeeping requirements in parts
108, 113 and 114, for a total of 2,598,000
hours.
Finally, our regulations require that
processors mark thermally processed
low-acid foods in hermetically sealed
containers (§ 113.60(c)) and acidified
foods (§ 114.80(b) (21 CFR 114.80(b))
with an identifying code to permit lots
to be traced after distribution. We seek
OMB approval of the third party
disclosure requirements in §§ 113.60(c)
and 114.80(b). However, we have not
included a separate table to report the
estimated burden of these regulations.
No burden has been estimated for the
third party disclosure requirements in
§§ 113.60(c) and 114.80(b) because the
coding process is done as a usual and
customary part of normal business
activities. Coding is a business practice
in foods for liability purposes, inventory
control, and process control in the event
of a problem. Under 5 CFR 1320.3(b)(2)),
the time, effort, and financial resources
necessary to comply with a collection of
information are excluded from the
burden estimate if the reporting,
recordkeeping, or disclosure activities
needed to comply are usual and
customary because they would occur in
the normal course of activities.
Dated: August 7, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–19241 Filed 8–13–14; 8:45 am]
tkelley on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1139]
Determination That DRIXORAL
(Dexbrompheniramine Maleate;
Pseudoephedrine Sulfate) Tablet and
Other Drug Products Were Not
Withdrawn From Sale for Reasons of
Safety or Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) has determined
that the drug products listed in this
document were not withdrawn from
sale for reasons of safety or
effectiveness. This determination means
that FDA will not begin procedures to
withdraw approval of abbreviated new
drug applications (ANDAs) that refer to
these drug products, and it will allow
FDA to continue to approve ANDAs that
refer to the products as long as they
meet relevant legal and regulatory
requirements.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Amy Hopkins, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6223,
Silver Spring, MD 20993–0002, 301–
796–5418, Amy.Hopkins@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In 1984,
Congress enacted the Drug Price
Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98–417)
(the 1984 amendments), which
authorized the approval of duplicate
versions of drug products approved
under an ANDA procedure. ANDA
applicants must, with certain
exceptions, show that the drug for
which they are seeking approval
contains the same active ingredient in
the same strength and dosage form as
the ‘‘listed drug,’’ which is a version of
the drug that was previously approved.
ANDA applicants do not have to repeat
the extensive clinical testing otherwise
necessary to gain approval of a new
drug application (NDA).
The 1984 amendments include what
is now section 505(j)(7) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
355(j)(7)), which requires FDA to
publish a list of all approved drugs.
FDA publishes this list as part of the
‘‘Approved Drug Products With
Therapeutic Equivalence Evaluations,’’
which is generally known as the
‘‘Orange Book.’’ Under FDA regulations,
a drug is removed from the list if the
Agency withdraws or suspends
approval of the drug’s NDA or ANDA
for reasons of safety or effectiveness or
if FDA determines that the listed drug
was withdrawn from sale for reasons of
safety or effectiveness (21 CFR 314.162).
Under § 314.161(a) (21 CFR
314.161(a)), the Agency must determine
whether a listed drug was withdrawn
from sale for reasons of safety or
effectiveness: (1) Before an ANDA that
refers to that listed drug may be
approved, (2) whenever a listed drug is
voluntarily withdrawn from sale and
ANDAs that refer to the listed drug have
been approved, and (3) when a person
petitions for such a determination under
21 CFR 10.25(a) and 10.30. Section
314.161(d) provides that if FDA
determines that a listed drug was
withdrawn from sale for safety or
effectiveness reasons, the Agency will
initiate proceedings that could result in
the withdrawal of approval of the
ANDAs that refer to the listed drug.
FDA has become aware that the drug
products listed in the table in this
document are no longer being marketed.
Application No.
Drug
Applicant
NDA 013483 ..............
DRIXORAL
(dexbrompheniramine
maleate
and
pseudoephedrine sulfate) Tablet, Extended Release;
Oral, 6 milligrams (mg)/120 mg.
AVENTYL (nortriptyline hydrochloride (HCl)) Solution; Oral,
Equivalent to (EQ) 10 mg Base/5mL.
MSD Consumer Care Inc., 556 Morris Ave., Summit, NJ
07901.
NDA 014685 ..............
VerDate Mar<15>2010
16:42 Aug 13, 2014
Jkt 232001
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Ranbaxy Pharmaceuticals Inc., 600 College Rd. East,
Princeton, NJ 08540.
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 79, Number 157 (Thursday, August 14, 2014)]
[Notices]
[Pages 47642-47648]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-19241]
[[Page 47642]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2013-N-1119]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Food Canning
Establishment Registration, Process Filing, and Recordkeeping for
Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically
Sealed Containers
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
September 15, 2014.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0037.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Food Canning Establishment Registration, Process Filing, and
Recordkeeping for Acidified Foods and Thermally Processed Low-Acid
Foods in Hermetically Sealed Containers--21 CFR 108.25 and 108.35, and
Parts 113 and 114 (OMB Control Number 0910-0037)--Revision
Section 402 of the Federal Food, Drug, and Cosmetic Act (the FD&C
Act) (21 U.S.C. 342) deems a food to be adulterated, in part, if the
food bears or contains any poisonous or deleterious substance which may
render it injurious to health. Section 301(a) of the FD&C Act (21
U.S.C. 331(a)) prohibits the introduction or delivery for introduction
into interstate commerce of adulterated food. Under section 404 of the
FD&C Act (21 U.S.C. 344), our regulations require registration of food
processing establishments, filing of process or other data, and
maintenance of processing and production records for acidified foods
and thermally processed low-acid foods in hermetically sealed
containers. These requirements are intended to ensure safe
manufacturing, processing, and packing procedures and to permit us to
verify that these procedures are being followed. Improperly processed
low-acid foods present life-threatening hazards if contaminated with
foodborne microorganisms, especially Clostridium botulinum. The spores
of C. botulinum need to be destroyed or inhibited to avoid production
of the deadly toxin that causes botulism. This is accomplished with
good manufacturing procedures, which must include the use of adequate
heat processes or other means of preservation.
To protect the public health, our regulations require that each
firm that manufactures, processes, or packs acidified foods or
thermally processed low-acid foods in hermetically sealed containers
for introduction into interstate commerce register the establishment
with us using Form FDA 2541 (Sec. Sec. 108.25(c)(1) and 108.35(c)(2)
(21 CFR 108.25(c)(1) and 108.35(c)(2))). In addition to registering the
plant, each firm is required to provide data on the processes used to
produce these foods, using Form FDA 2541a for all methods except
aseptic processing, or Form FDA 2541c for aseptic processing of low-
acid foods in hermetically sealed containers (Sec. Sec. 108.25(c)(2)
and 108.35(c)(2)). Plant registration and process filing may be
accomplished simultaneously. Process data must be filed prior to
packing any new product, and operating processes and procedures must be
posted near the processing equipment or made available to the operator
(21 CFR 113.87(a)).
Regulations in parts 108, 113, and 114 (21 CFR parts 108, 113, and
114) require firms to maintain records showing adherence to the
substantive requirements of the regulations. These records must be made
available to FDA on request. Firms also must document corrective
actions when process controls and procedures do not fall within
specified limits (Sec. Sec. 113.89, 114.89, and 114.100(c)); report
any instance of potential health-endangering spoilage, process
deviation, or contamination with microorganisms where any lot of the
food has entered distribution in commerce (Sec. Sec. 108.25(d) and
108.35(d) and (e)); and develop and keep on file plans for recalling
products that may endanger the public health (Sec. Sec. 108.25(e) and
108.35(f)). To permit lots to be traced after distribution, acidified
foods and thermally processed low-acid foods in hermetically sealed
containers must be marked with an identifying code (Sec. Sec.
113.60(c) (thermally processed foods) and 114.80(b) (acidified foods)).
The records of processing information are periodically reviewed
during factory inspections by FDA to verify fulfillment of the
requirements in 21 CFR parts 113 or 114. Scheduled thermal processes
are examined and reviewed to determine their adequacy to protect public
health. In the event of a public health emergency, records are used to
pinpoint potentially hazardous foods rapidly and thus limit recall
activity to affected lots.
As described in our regulations, processors may obtain the paper
versions of Forms FDA 2541, FDA 2541a, and FDA 2541c by contacting us
at a particular address. Processors mail completed paper forms to us.
However, processors who are subject to Sec. Sec. 108.25, 108.35, or
both, have an option to submit Forms FDA 2541, FDA 2541a, and FDA 2541c
electronically (see 76 FR 11783 at 11785, March 3, 2011).
In a notice published in the Federal Register of September 18, 2013
(78 FR 57391) (the September 18, 2013 notice), we provided notice that
we are updating the process filing portion of the electronic submission
system to incorporate ``smartform'' technology. The updated process
filing portion of the electronic submission system will query the
processor about the processes used to produce the food and present only
those data entry fields that are applicable. This will reduce the
burden on processors and reduce errors in process filing because
processors will no longer need to evaluate whether particular data
entry fields are applicable to their products. For example, when a
processor submits a process filing for a product that is processed
using a low-acid retorted method with a process mode of ``agitating,''
smartform technology would bypass questions that are not applicable to
this process mode option.
Although we encourage commercial processors to use the electronic
submission system for plant registration and process filing, we will
continue to make paper-based forms available. To standardize the burden
associated with process filing, regardless of whether the process
filing is submitted electronically or using a paper form, we are
proposing to eliminate Forms FDA 2541a and FDA
[[Page 47643]]
2541c and replace these two forms with a total of four forms. Each of
the four proposed replacement forms will pertain to a specific type of
commercial processing and will be available both on the electronic
submission system and as a paper-based form. The electronic submission
system and the paper-based form will ``mirror'' each other to the
extent practicable. The four proposed replacement process filing forms
are as follows:
Form FDA 2541d (Food Process Filing for Low-Acid Retorted
Method);
Form FDA 2541e (Food Process Filing For Acidified Method);
Form FDA 2541f (Food Process Filing for Water Activity/
Formulation Control Method); and
Form FDA 2541g (Food Process Filing for Low-Acid Aseptic
Systems).
Some of the data entry fields on the four proposed replacement
process filing forms are not on current Forms FDA 2541a and FDA 2541c.
We added certain data entry fields to improve the efficiency of our
review of the process filings. For example, the four proposed
replacement forms include data entry fields for the ``food product
group'' (such as liquid, ready-to-eat ``breakfast foods''). We estimate
that any time it would take to provide such information not already on
Form FDA 2541a or FDA 2541c would be offset by the time processors will
save by not having to evaluate whether certain data entry fields on
Form FDA 2541a or FDA 2541c are applicable to their products.
In accordance with 5 CFR 1320.8(d), we requested public comment on
the proposed information collection in the September 18, 2013, notice.
We extended the comment period for an additional 90 days on November
18, 2013. We received five comments in response to the notice, each
addressing one or more topics.
(Comment 1) One comment expressed concern that it would have to
resubmit all previously submitted process filings.
(Response) There is no need to resubmit previously submitted
process filings. Previously submitted process filings will remain valid
provided that the information in the previously submitted filings is
still current.
(Comment 2) One comment expressed concern that we are planning to
eliminate electronic submission.
(Response) We are not planning to eliminate electronic submission
for process filing and registration. When we published the notice on
September 18, 2013, we made the revised paper forms available for
review so that interested parties could comment on their content and
format. As a result of the comments, we have updated the draft revised
forms. Once we receive OMB approval of the revised information
collection, we will update the electronic system so that the
information requested in the electronic system mirrors the information
requested on the revised paper forms.
(Comment 3) One comment asserted that we do not have legal
authority to use Form FDA 2541e for the purpose of submitting a
voluntary process filing.
(Response) We disagree with the comment's assertion that we do not
have the legal authority to permit a manufacturer to provide a
voluntary process filing submission to FDA on Form FDA 2541e. The scope
of the voluntary submission discussed in this document is limited to
certain food products (that is, fermented foods that have a finished
equilibrium pH of 4.6 or below and acid foods with small amounts of
added low-acid ingredients) whose regulatory classification is not
obvious when we look at the product and the product label. FDA has long
regarded it to be a prudent practice for manufacturers of foods to work
cooperatively with FDA to ensure that their products are safe and
comply with all applicable legal requirements. Consequently, we have
proposed to institute the voluntary consultation process discussed in
this document. The draft guidance document, ``Guidance for Industry:
Submitting Form FDA 2541 (Food Canning Establishment Registration) and
Forms FDA 2541d, FDA 2541e, FDA 2541f, and FDA 2541g (Food Process
Filing Forms) to FDA in Electronic or Paper Format (January 2014),''
available on FDA's Web site at https://www.fda.gov/FoodGuidances,
describes the scope and purpose of this process in section II.C, and we
expect to issue final guidance on or about the date that Form FDA 2541e
becomes operational, along with the other revised forms discussed in
this document. The ability to submit a voluntary submission fosters
communication by encouraging manufacturers to submit their processing
techniques to FDA for an early evaluation of whether their product
satisfies the criteria for being excluded from the coverage of part
114. Such communication will help to ensure that any potential food
safety issues are resolved before the product is marketed and will help
to ensure that processing techniques used by manufacturers are in full
compliance with the standards of the FD&C Act. FDA is instituting this
voluntary consultation process under our broad statutory authority,
found in section 1003 of the FD&C Act (21 U.S.C. 393), to protect the
public health by ensuring that foods are safe, wholesome, sanitary, and
properly labeled and the prohibitions regarding adulterated food in
section 402(a)(1) of the FD&C Act (21 U.S.C. 342(a)(1)).
(Comment 4) One comment expressed concern that a manufacturer of a
product that satisfies the criteria for being excluded from the
coverage of part 114 who submits a voluntary submission will be held to
the same regulations that acidified products are held to with regard to
inspections and recordkeeping. As a result, we would be making
substantial changes to part 114 without notice and comment rulemaking.
(Response) A voluntary process filing submission to FDA on Form FDA
2541e allows manufacturers to submit their processing techniques to FDA
for an early evaluation of whether their product satisfies the criteria
for being excluded from the coverage of part 114. If the product
satisfies the criteria for being excluded from the coverage of part
114, the product is not subject to the inspection and recordkeeping
regulations in part 114 and has not become subject to those regulations
as a result of the submission and consultation. However, if after
careful review of the voluntary submission we conclude that the product
does not satisfy the criteria for being excluded from the coverage of
part 114, then we would advise the manufacturer of our determination
that the product is an acidified food subject to part 114 and that a
process filing as an acidified food must be submitted for the product.
(Comment 5) One comment expressed concern that the ``voluntary
process filing'' is not ``voluntary'' because it asserted our
inspectors will expect all manufacturers of products that are excluded
from the coverage of part 114 to voluntarily file, thereby making the
process effectively mandatory.
(Response) The voluntary submission process is only available to
manufacturers of certain food products (that is, fermented foods that
have a finished equilibrium pH of 4.6 or below and acid foods with
small amounts of added low-acid ingredients) whose regulatory
classification is not obvious when we look at the product and the
product label. For example, we can easily determine that products such
as refrigerated foods and carbonated beverages are excluded from the
coverage of part 114 by looking at the product or the product label. In
response to comments, we have revised our guidance and the instructions
for voluntary submissions to clarify those products for which a
voluntary
[[Page 47644]]
submission would or would not be accepted. In the event that we receive
a voluntary submission for a product that is not eligible for the
review, we will respond to the submission by notifying the manufacturer
of the error. We will not add the product to our database. Thus,
ineligible submissions will be rejected and will not result in
additional information in our database. In summary, our inspectors will
not expect all manufacturers to submit voluntary submissions because
not all products are eligible for the process and no advantage is
obtained from a voluntary submission for an ineligible product.
(Comment 6) One comment expressed concern that voluntary submitters
who choose to use the electronic submission system would not be able to
access and view their submissions.
(Response) A voluntary submission on Form FDA 2541e that is
submitted electronically may be accessed and viewed in the same manner
as a required process filing on Form FDA 2541e that is submitted
electronically.
(Comment 7) One comment suggested that voluntary submission may
create confusion by subjecting a non-covered product (that is a
refrigerated food or a fermented food) to the acidified food
regulations,
(Response) As discussed in the response to Comment 4, if a product
satisfies the criteria for being excluded from the coverage of part
114, the product is not subject to the inspection and recordkeeping
regulations in part 114 and will not become subject to those
regulations as a result of a voluntary submission. We can easily
determine that some products such as refrigerated foods and carbonated
beverages are excluded from the coverage of part 114 by looking at the
product or the product label. The voluntary submission process is only
available to manufacturers of certain food products (that is, fermented
foods that have a finished equilibrium pH of 4.6 or below and acid
foods with small amounts of added low-acid ingredients) whose
regulatory classification is not obvious when we look at the product
and the product label.
(Comment 8) One comment stated that the current, ``Acidified and
Low-Acid Canned Foods: Draft Guidance: Acidified Foods (September,
2010),'' does not provide guidance on what constitutes a fermented
food.
(Response) As discussed in section III.C of the guidance, fermented
foods (such as some kinds of sauerkraut, cucumber pickles, and green
olives) are low acid foods that have been subjected to the action of
microorganisms to reduce the pH of the food to 4.6 or below.
(Comment 9) One comment suggested that the voluntary submission
process creates unnecessary burdens for both industry and FDA and that
there will be no benefit derived from the consultation process.
(Response) Manufacturers are free to decide whether to make a
voluntary submission, and we believe that some manufacturers may choose
to do so to participate in the voluntary consultation process. Such
consultation may enable us to more easily determine the regulatory
classification of a product. For a domestic product, this may reduce
the time it takes for us to complete a facility inspection. With regard
to a food product that will be offered for import into the United
States, this may enable us to reduce the time it takes to authorize
release of the product at the border. For FDA, the voluntary submission
results in increased efficiency.
(Comment 10) Because FDA Form 2541e does not have to be filled out
in its entirety, the comment argued that voluntary filing does not
result in benefits to food safety. The comment suggested that a better
voluntary program would be one in which a processor could submit a
scheduled process for a food to seek our assessment of the systems in
place to assure the safety of the food, not just as a way to determine
if a product is acidified or not.
(Response) As discussed in the response to Comment 4, a voluntary
process filing submission to FDA on Form FDA 2541e allows manufacturers
to submit their processing techniques to FDA for an early evaluation of
whether their product satisfies the criteria for being excluded from
the coverage of part 114. If we conclude that the product does not
satisfy the criteria for being excluded from the coverage of part 114,
then we would advise the manufacturer of our determination that the
product is an acidified food subject to part 114 and that a process
filing as an acidified food must be submitted for the product. This
results in proper regulatory classification of the product and
appropriate FDA review of the processing technique, thereby enhancing
food safety.
We appreciate the comment's suggestions for expanding the voluntary
submission program, but we note that the expansion suggested by the
comment is not within the scope of the revisions to Form FDA 2541e. The
paperwork reduction analysis only estimates the additional paperwork
burden associated with voluntary submission on Form FDA 2541e of
information for food products, limited to those the regulatory
classification of which is not obvious when we look at the product and
the product label.
(Comment 11) One comment suggested that Form FDA 2541e does not
provide the flexibility needed for manufacturers to report their
processes. The comment indicated that the draft form only provides
``one size fits all'' mandatory processing parameters by listing
limited options for processors to choose from.
(Response) When we revised Form FDA 2541e, we listed all the
current processing methods used by industry, and included an ``Other''
choice for many fields to permit manufacturers to report new and
emerging methods that may be developed in the future. As a result of
these revisions, the form provides the flexibility needed to describe
any process. In addition, we issued a draft guidance describing the
revised forms and provided interested parties an opportunity to comment
on alternative processes that we should include on the forms.
(Comment 12) One comment suggested that a processor should be able
to submit one Form FDA 2541e that describes a process for multiple
forms of a product (e.g., ``fresh pack pickles (whole, cut or
sliced)''), multiple product packing mediums, and multiple product
names that indicate minor formulation changes, provided that the
preparation of these products follows the identical scheduled process.
(Response) We agree that, under the appropriate circumstances, a
processor should be able to submit one paper Form FDA 2541e that
describes a process for multiple forms of a product. In the past, a
processor could complete Form FDA 2541e in the manner described. The
revised paper version of Form FDA 2541e may still be prepared in this
manner, provided that the multiple forms of the product all follow the
identical scheduled process and other factors (e.g., container type or
size) do not make it necessary to submit a separate filing. The paper
version of revised Form FDA 2541e will allow a processor to enter (1)
multiple product forms (e.g., ``fresh pack pickles (whole, cut or
sliced)''), (2) multiple product packing mediums (such as brine, oil,
sauce), and (3) multiple product names that indicate minor formulation
changes (such as hot, medium, mild salsa).
(Comment 13) One comment stated that we do not need percent
headspace information on a process filing for an acidified product and,
if the form includes the data element, then we should provide enough
room on the
[[Page 47645]]
form for a processor to identify multiple percent headspace figures
associated with multiple container sizes.
(Response) Information regarding the percent headspace information
on a process filing for an acidified product may help us analyze a
processing method that uses overpressure. While overpressure typically
is used for low acid products that are thermally processed at elevated
temperatures, overpressure may also be used for an acidified product.
Thus, revised Form FDA 2541e includes a data field for percent
headspace. If overpressure is not being used, the correct response is
``N/A.''
We also disagree that we should allow a processor to identify
multiple figures associated with multiple container sizes on a single
process filing. A process filing may not be submitted for multiple
container types or sizes to prevent the detention of product where
multiple types or sizes are on one submission and only part of the
submission (e.g., one container size and/or type) is questionable from
a food safety perspective. A separate Form FDA 2541e is needed for each
container type or size. Because a separate Form FDA 2541e is needed for
each container type or size, room for multiple entries for headspace
associated with multiple container sizes is not necessary.
(Comment 14) One comment suggested that we clarify how to complete
the data field, ``What is the vacuum,'' in section C.2 of revised Form
FDA 2541e when the processor has a range of values to report.
(Response) We revised the instructions for section C.2 of Form FDA
2541e to clarify that the processor of an acidified food that is vacuum
packed should report the minimum value if there is a range of values
for the vacuum.
(Comment 15) One comment suggested that we add ``Center
Temperature'' as a thermal process mode in section G of revised Form
FDA 2541e. The comment described ``Center Temperature'' as a process in
which the processor punctures the lid and inserts a thermometer into
the container to take a center temperature reading. When the center
temperature reaches the appropriate temperature, the processor begins
the time count. The comment explained that the center temperature
method differs from the other methods because the time count does not
begin when the container is filled or the lid is placed on the
container but instead begins when the center temperature reaches the
specified temperature. In addition, the comment requests that center
temperature be added as a choice in the ``Note'' under Section D
(Container Size) that references specific thermal processing mode for
which the processor may choose to report volume rather than container
dimensions.
(Response) We disagree with the comment's suggestion to add
``Center Temperature'' as a thermal process mode in section G and as a
choice in the ``Note'' under section D of revised Form FDA 2541e.
``Center temperature'' is not a thermal process mode because it does
not include a defined scheduled process. A scheduled process for
acidified foods can consist of a minimum of two components as in the
case of a ``hot fill and hold'' or as many as three components for
products that are processed using one of the other processing modes
selected. The term ``center temperature'' or ``center can temperature''
refers to the temperature of the product achieved at the end of the
completed scheduled process and not a thermal process mode in and of
itself.
(Comment 16) One comment suggested that we clarify where to report
the maximum pH value on Form FDA 2541e.
(Response) We no longer request the maximum pH value of the product
on draft Form FDA 2541e. We revised the form to refer to the ``finished
equilibrium pH'' value of the product for consistency with the use of
that term in Sec. 114.80. We revised the instructions for section E.2
of Form FDA 2541e to clarify that the finished equilibrium pH should be
reported.
(Comment 17) One comment suggested that we add ``critical to the
scheduled process'' to the term ``Microbial Preservative(s)'' in
section E.6 of draft Form FDA 2541e. The comment explained that some
preservatives are added for purposes other than controlling the growth
of microorganisms and should not be part of the scheduled process.
(Response) We revised the title of section E.6 of draft Form FDA
2541e to read ``Microbial Preservative(s) Critical to the Scheduled
Process.''
(Comment 18) One comment suggested we clarify that trade
associations are an appropriate source for a scheduled process.
(Response) Trade associations may provide the scientific support
for a scheduled process. In response to the comment, we have revised
our instructions to include a reference to ``organization'' which by
definition would include trade associations in the list of examples for
the term ``process source.''
(Comment 19) One comment asked us to clarify how to fill out
section I on Form FDA 2541e for companies that use center temperature,
particularly with respect to columns 1, 2, 3, 5, and 7.
(Response) As discussed in the response to Comment 15, we disagree
that ``center temperature'' is a thermal process mode. The term
``center temperature'' or ``center can temperature'' refers to the
temperature of the product achieved at the end of the completed
scheduled process and not a thermal process mode in and of itself. The
center temperature is the end point achieved by the scheduled process
and is not the scheduled process itself. The instructions for Form FDA
2541e provide step-by-step directions for how to fill out each section
of the form.
(Comment 20) One comment noted that the draft guidance document,
``Acidified and Low-Acid Canned Foods: Draft Guidance: Acidified Foods
(September, 2010),'' has not been finalized and suggested that we
should refrain from revising the process filing forms until the
guidance has become final. The comment expressed concern that the
``Food Product Group'' categories might be affected by possible changes
to the draft guidance.
(Response) The draft acidified foods guidance is intended to help
commercial food processors in determining whether their food products
are subject to the regulations for acidified foods and provides our
thinking on several topics related to the processing of, and process
filings for, acidified foods. We have prepared a separate draft
guidance document that focuses on procedures for submitting the revised
process filing forms. The draft guidance entitled ``Guidance for
Industry: Submitting Form FDA 2541 (Food Canning Establishment
Registration) and Forms FDA 2541d, FDA 2541e, FDA 2541f, and FDA 2541g
(Food Process Filing Forms) to FDA in Electronic or Paper Format
(January 2014),'' is available on FDA's Web site at https://www.fda.gov/FoodGuidances. As discussed in the response to Comment 3, we expect to
issue this guidance as final guidance on or about the date that the
revised forms become operational. Further, we disagree that the ``Food
Product Group'' categories might be affected by possible changes to the
draft acidified foods guidance. The ``Food Product Group'' categories
correspond to the first two digits of the FDA Product Code and would
not be affected by changes to the draft acidified foods guidance.
(Comment 21) One comment suggested that we remove the ``Food
Product Groups'' category of ``Dressings/condiments (e.g. salad
dressing, chutney, salsa, pepper sauce, etc.)'' from all process filing
forms because all
[[Page 47646]]
dressings and sauces with a pH of 4.6 or below should be considered
acid foods.
(Response) The definition of acidified foods in Sec. 114.3(b) only
excludes from the coverage of part 114 those dressing and condiments
that are acid foods that contain small amounts of low-acid ingredients
and have a resultant finished equilibrium pH that does not
significantly differ from that of the predominant acid or acid food. We
included the ``Food Product Group'' category, ``Dressings/condiments
(e.g. salad dressing, chutney, salsa, pepper sauce, etc.),'' on the
forms to accommodate the possibility that some dressings and condiments
may not satisfy these criteria.
(Comment 22) One comment expressed concern that the ``Food Product
Group'' categories for various fruit and vegetable juices indicates
that FDA considers all fruit and vegetable juices to be subject to the
acidified foods regulations and, therefore, will require process
filings for all fruit and vegetable juices.
(Response) The definition of acidified foods in Sec. 114.3(b)
excludes from the coverage of part 114 those fruit and vegetable juices
that meet the definition of 21 CFR 120.1(a) and have a finished natural
pH of 4.6 or below. We included ``Food Product Group'' categories for
various fruit and vegetable juices on all the forms (forms for low-acid
foods as well as forms for acidified foods) to accommodate the
possibility that some fruit and vegetable juices may not satisfy these
criteria.
(Comment 23) One comment suggested we should eliminate the optional
``Food Product Group'' categories from the process filing forms to make
the forms easier to complete.
(Response) Because the ``Food Product Group'' information is
optional, a manufacturer or packer that chooses not to provide the
information may simply skip that section of the form.
(Comment 24) One comment questioned the value of the optional
``Food Product Group'' category information. Another comment asserted
that parts of the revised forms appear to be directed toward generating
what it characterized as facility profiles, which it further
characterized as extraneous information not relevant to public safety
and, thus, unnecessary.
(Response) As discussed in section I of this notice, improperly
processed low-acid foods present life-threatening hazards if
contaminated with foodborne microorganisms, especially C. botulinum.
The spores of C. botulinum need to be destroyed or inhibited to avoid
production of the deadly toxin that causes botulism. This is
accomplished with good manufacturing procedures, which must include the
use of adequate heat processes or other means of preservation. To
protect the public health, our regulations in parts 108, 113, and 114
require registration of food processing establishments, filing of
process or other data, and maintenance of processing and production
records for acidified foods and thermally processed low-acid foods in
hermetically sealed containers. We review the process filings to
determine their adequacy to protect public health. In the event of a
public health emergency, records are used to pinpoint potentially
hazardous foods rapidly and thus limit recall activity to affected
lots.
We interpret the comment regarding ``facility profiles'' as
objecting to our intent to permit manufacturers to voluntarily self-
categorize the product for which they are submitting a process filing
as one of several optional ``Food Product Group'' categories. When this
optional information about the ``Food Product Group'' category is
provided, we will use it to help us understand the nature of the
products covered by the process filing as we review the scheduled
process described in the filing for adequacy to control microbial
contamination to ensure safe manufacturing, processing, and packing
procedures. We will also use the ``Food Product Group'' category
information, in addition to our general knowledge of the industry and
the reports we receive, such as those under Sec. Sec. 108.25(d) and
108.35(d) regarding instances of potential health-endangering spoilage,
process deviation, or contamination with microorganisms, to prioritize
which facilities to inspect.
(Comment 25) One comment suggested that, to eliminate confusion, we
should use ``import codes'' from the U.S. International Trade
Commission to clarify the ``Food Product Group'' categories.
(Response) We disagree that using a coding system such as the
``Harmonized Tariff Schedule of the United States Annotated'', which
provides the applicable tariff rates and statistical categories for all
merchandise imported into the United States, would eliminate confusion.
The ``Food Product Group'' categories identifies to FDA a ``group'' of
foods that will help us determine the product submission (such as Baby
Food or Soup) and prioritize facilities to inspect from a food safety
perspective. The ``Food Product Group'' categories correspond to the
first two digits of the FDA Product Code, also referred to as the
Product Industry Code. We have been using this coding system for
decades, and so we believe that using ``import codes'' rather than our
longstanding coding system would not enhance our ability to track and
identify potentially adulterated products as well as groups of foods
for potential health hazards.
(Comment 26) One comment asserted that we have increased the
information being requested by 30 percent and, since this increase
should be reflected in the time needed to complete the forms, we
underestimated the reporting burden in table 1.
(Response) We disagree that we have increased the information being
requested or underestimated the time it takes to complete the paper
forms. We updated the paper forms to provide responsive information in
the form of check boxes. This responsive information has been reported
by industry for decades without being provided as check boxes on the
paper forms. Adding these check boxes makes the forms longer, but does
not increase the information being requested. Instead, the new forms
should reduce the time it takes to complete the process filing because
a submitter may check a box rather than prepare and manually enter on
the paper form a written description of a process. We note that
substantial time may be saved by submitters that use the electronic
submission system. The electronic submission system will present only
those sections of the form that are relevant to the subject matter of
the submission, as determined by the information submitted in response
to the initial questions. The system will also minimize the submission
of incomplete forms, thus saving time that paper form submitters will
spend if it becomes necessary to correct a form and submit it again.
Finally, we note that, to the extent that the comment is referring to
the optional ``Food Product Group'' categories, we estimate that the
information is readily available to a submitter and easily provided by
checking a box. In summary, we have not increased or decreased our
estimate of the total time necessary to complete the new process filing
forms because: (1) We have not increased the required information in a
process filing; (2) the new forms should reduce the time it takes to
complete the process filing because a submitter may check a box rather
than prepare and manually enter on the form a written description of a
process; and (3) the ``Food Product Group'' category information is
optional, readily available, and provided by checking a box.
(Comment 27) One comment asserted that we underestimated the
[[Page 47647]]
number of hours it takes to comply with recordkeeping requirements in
parts 108, 113, and 114, as reported in table 2. The comment stated
that a canning establishment running a single line operation with one
8-hour shift 5 days a week for 52 weeks each year would conduct
manufacturing operations for 2,080 hours each year, and the
recordkeeping would occupy 25 percent of the time of one full-time
employee, or 520 hours per year, which is greater than our estimate of
250 hours. The comment added that, for a facility operating multiple
processing lines and/or multiple shifts per day, the recordkeeping
burden would be greater.
(Response) We appreciate the information provided by the comment.
Since the information relates the recordkeeping experience of a single
line operation, without additional information we do not have a
sufficient basis for revising the estimated average number of hours of
recordkeeping undertaken by all respondents, across various sizes and
types of processing facilities. Accordingly, for the purpose of this
information collection request, we are retaining our previous estimate.
However, in preparation for the next regular information collection
request, we will consult with several establishments of varying sizes
and types to obtain additional data on the recordkeeping burdens and
reevaluate our estimates. We will then publish the revised estimates
for comment and consider additional information submitted in response.
(Comment 28) One comment asked us to consult select companies
before finalizing the revised forms, in order to obtain these
companies' recommendations regarding the content of the forms, as part
of a transparent, collaborative effort.
(Response) Section 3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires us to provide notice and a 60-day comment
period before submitting the information collection to OMB. Section
3507(a)(1)(D) of the PRA (44 U.S.C. 3507(a)(1)(D)) requires us to
publish a second notice announcing our submission of the Information
Collection Request to OMB and providing a 30-day comment period during
which interested parties may submit their comments directly to OMB.
These processes are open to all interested parties rather than to
``select companies.'' Thus, interested parties had sufficient
opportunity to comment.
As discussed in our responses to the comments, we have modified the
paper-based versions of the four proposed replacement forms and their
instructions. We have also modified the electronic submission system to
mirror the paper forms. At this time, these documents are available for
review on OMB's Web site as part of the Information Collection Request
we submitted to OMB.
Description of Respondents: The respondents to this information
collection are commercial processors and packers of acidified foods and
thermally processed low-acid foods in hermetically sealed containers.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR section FDA form Number of responses per Total annual Average burden per response Total
number respondents respondent responses hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
108.25(c)(1) and 108.35(c)(2); Food 2541 645 1 645 0.17 (10 mins.)................... 110
canning establishment registration.
108.25(c)(2); Food process filing for 2541e 726 11 7,986 0.33 (20 mins.)................... 2,659
acidified method.
108.35(c)(2); Food process filing for low- 2541d 336 12 4,032 0.33 (20 mins.)................... 1,343
acid retorted method.
108.35(c)(2); Food process filing for 2541f 37 6 222 0.33 (20 mins.)................... 74
water activity/formulation control method.
108.35(c)(2); Food process filing for low- 2541g 42 22 924 0.75 (45 mins.)................... 693
acid aseptic systems.
108.25(d); 108.35(d) and (e); Report of N/A 1 1 1 4................................. 4
any instance of potential health-
endangering spoilage, process deviation,
or contamination with microorganisms
where any lot of the food has entered
distribution in commerce.
-------------------------------------------------------------------------------------------------------------
Total................................. .............. .............. .............. .............. .................................. 4,883
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of the number of respondents in table 1 on
registrations, process filings, and reports received over the past 3
years. The hours per response reporting estimates are based on our
experience with similar programs and information received from
industry. The reporting burden for Sec. Sec. 108.25(d) and 108.35(d)
and (e) is minimal because notification of spoilage, process deviation,
or contamination of product in distribution occurs less than once a
year. Most firms discover these problems before the product is
distributed and, therefore, are not required to report the occurrence.
We estimate that we will receive one report annually under Sec. Sec.
108.25(d) and 108.35(d) and (e). The report is expected to take 4 hours
per response, for a total of 4 hours.
[[Page 47648]]
Table 2--Estimated Annual Recordkeeping Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
21 CFR section Number of records per Total annual per Total hours
recordkeepers recordkeeper records recordkeeping
--------------------------------------------------------------------------------------------------------------------------------------------------------
113.100 and 114.100................................................ 10,392 1 10,392 250 2,598,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of 10,392 recordkeepers in table 2 on its
records of the number of registered firms, excluding firms that were
inactive or out of business, yet still registered. To avoid double-
counting, we have not included estimates for Sec. 108.25(e), (g), and
(h) because they merely cross-reference recordkeeping requirements
contained in parts 113 and 114 and have been accounted for in the
recordkeeping burden estimate. We estimate that 10,392 firms will
expend approximately 250 hours per year to fully satisfy the
recordkeeping requirements in parts 108, 113 and 114, for a total of
2,598,000 hours.
Finally, our regulations require that processors mark thermally
processed low-acid foods in hermetically sealed containers (Sec.
113.60(c)) and acidified foods (Sec. 114.80(b) (21 CFR 114.80(b)) with
an identifying code to permit lots to be traced after distribution. We
seek OMB approval of the third party disclosure requirements in
Sec. Sec. 113.60(c) and 114.80(b). However, we have not included a
separate table to report the estimated burden of these regulations. No
burden has been estimated for the third party disclosure requirements
in Sec. Sec. 113.60(c) and 114.80(b) because the coding process is
done as a usual and customary part of normal business activities.
Coding is a business practice in foods for liability purposes,
inventory control, and process control in the event of a problem. Under
5 CFR 1320.3(b)(2)), the time, effort, and financial resources
necessary to comply with a collection of information are excluded from
the burden estimate if the reporting, recordkeeping, or disclosure
activities needed to comply are usual and customary because they would
occur in the normal course of activities.
Dated: August 7, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-19241 Filed 8-13-14; 8:45 am]
BILLING CODE 4164-01-P